These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9709282)

  • 1. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials.
    Hendrick RE; Smith RA; Rutledge JH; Smart CR
    J Natl Cancer Inst Monogr; 1997; (22):87-92. PubMed ID: 9709282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials.
    Smart CR; Hendrick RE; Rutledge JH; Smith RA
    Cancer; 1995 Apr; 75(7):1619-26. PubMed ID: 8826919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the International Workshop on Screening for Breast Cancer.
    Fletcher SW; Black W; Harris R; Rimer BK; Shapiro S
    J Natl Cancer Inst; 1993 Oct; 85(20):1644-56. PubMed ID: 8105098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 1997; (22):79-86. PubMed ID: 9709281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
    Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
    Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening outcomes in women ages 40-49: clinical experience with service screening using modern mammography.
    Sickles EA
    J Natl Cancer Inst Monogr; 1997; (22):99-104. PubMed ID: 9709284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing the benefits of screening mammography for women 40-49 years old.
    Bastardis-Zakas K; Iatrakis G; Navrozoglou I; Peitsidis P; Salakos N; Malakassis P; Zervoudis S
    Clin Exp Obstet Gynecol; 2010; 37(4):278-82. PubMed ID: 21355457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization.
    Larsson LG; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L; Nyström L
    J Natl Cancer Inst Monogr; 1997; (22):57-61. PubMed ID: 9709277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening among women in their forties: an overview of the issues.
    Fletcher SW
    J Natl Cancer Inst Monogr; 1997; (22):5-9. PubMed ID: 9709267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
    Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts.
    Nystrom L; Larsson LG; Wall S; Rutqvist LE; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabar L
    J Med Screen; 1996; 3(2):85-7. PubMed ID: 8849766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Fu R; Cantor A; Pappas M; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):244-55. PubMed ID: 26756588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening mammography for early diagnosis of breast cancer: facts, controversies, and the implementation in Israel].
    Allweis TM; Nissan A; Spira RM; Sklair-Levy M; Freund HR; Peretz T
    Harefuah; 2003 Apr; 142(4):281-6, 317. PubMed ID: 12754879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUSOMA review of mammography screening.
    Hackshaw A
    Ann Oncol; 2003 Aug; 14(8):1193-5. PubMed ID: 12881375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic breast cancer screening. Part II. Non-randomised comparisons: results similar to those of randomised trials.
    Prescrire Int; 2015 Apr; 24(159):99-102. PubMed ID: 25941706
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.